Cambridge University Hospitals Nhs Foundation Trust

This study tests whether combining two existing cancer drugs (pembrolizumab and olaparib) can help control advanced pancreatic cancer that has spread and has specific genetic features. The trial will enroll 20 patients who have already tried one prior treatment. Researchers will …

This study is testing whether time-restricted eating—limiting all daily food intake to a 9-hour window—can improve heart and metabolic health in people with obesity and prediabetes. It will involve 100 participants who will follow this eating pattern for 12 weeks without trying t…

This pilot study compares two approaches for treating high blood pressure in young adults who are overweight or obese. Researchers will test whether new weight loss medications (like tirzepatide) can lower blood pressure more effectively than standard treatments that use blood pr…

This trial is testing whether a new drug called dapansutrile can slow the progression of Parkinson's disease by reducing inflammation in the brain and body. Researchers will enroll 36 people with early-stage Parkinson's to take either the drug or a placebo pill daily for six mont…